Metrorrhagia - CISMeF

Preferred Label : Metrorrhagia;

NCIt related terms : Intermenstrual Bleeding;

Alternative definition : FDA: Uterine bleeding that occurs during a time not associated with the normal menstrual period.;

FDA table : Patient Code (Appendix B);

Codes from synonyms : 2665;

Détails

Origin ID

C34818;

UMLS CUI

C0025874;

Currated CISMeF NLP mapping
- Bleeding between periods (finding) [SNOMED CT concept]
- Intermenstrual bleeding [ICD-11 Sub-sub category]
- Irregular intermenstrual bleeding (finding) [SNOMED CT concept]
- METRORRHAGIA [WHO-ART Included Term]
- Metrorrhagia [PASCAL descriptor]
- Metrorrhagia [ICD-9 code]
- Metrorrhagia [MedDRA LLT]
- Metrorrhagia [HPO term]
- Metrorrhagia [MedDRA Preferred Term]
- intermenstrual bleeding [ICPC-2 Rubric]
- metrorrhagia [Disease (Nov.)]
- metrorrhagia [MeSH Descriptor]
- metrorrhagia [MeSH concept]
- metrorrhagia [SNOMED Notion]
Peut être observé dans la(les) pathologie(s)
- Advanced Endometrial Adenocarcinoma [NCIt concept]
- Advanced Endometrial Carcinoma [NCIt concept]
- Advanced Endometrial Endometrioid Adenocarcinoma [NCIt concept]
- Advanced Endometrial Serous Adenocarcinoma [NCIt concept]
- Advanced Endometrial Undifferentiated Carcinoma [NCIt concept]
- Advanced Microsatellite Stable Endometrial Carcinoma [NCIt concept]
- Childhood Ovarian Sertoli-Leydig Cell Tumor [NCIt concept]
- DICER1-Mutant Ovarian Sertoli-Leydig Cell Tumor [NCIt concept]
- DICER1/FOXL2-Wildtype Ovarian Sertoli-Leydig Cell Tumor [NCIt concept]
- Early Stage Endometrial Carcinoma [NCIt concept]
- Endometrial Adenocarcinoma [NCIt concept]
- Endometrial Adenosquamous Carcinoma [NCIt concept]
- Endometrial Cancer by FIGO Stage 2023 [NCIt concept]
- Endometrial Cancer with Molecular Classification by FIGO Stage 2023 [NCIt concept]
- Endometrial Carcinoma [NCIt concept]
- Endometrial Carcinoma Molecular Subtypes [NCIt concept]
- Endometrial Clear Cell Adenocarcinoma [NCIt concept]
- Endometrial Dedifferentiated Carcinoma [NCIt concept]
- Endometrial Endometrioid Adenocarcinoma [NCIt concept]
- Endometrial Endometrioid Adenocarcinoma with Clear Cell Change [NCIt concept]
- Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells [NCIt concept]
- Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component [NCIt concept]
- Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component [NCIt concept]
- Endometrial Endometrioid Adenocarcinoma, Ciliated Variant [NCIt concept]
- Endometrial Endometrioid Adenocarcinoma, Secretory Variant [NCIt concept]
- Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation [NCIt concept]
- Endometrial High Grade Endometrioid Adenocarcinoma [NCIt concept]
- Endometrial Large Cell Neuroendocrine Carcinoma [NCIt concept]
- Endometrial Low Grade Endometrioid Adenocarcinoma [NCIt concept]
- Endometrial Mesonephric-Like Adenocarcinoma [NCIt concept]
- Endometrial Mixed Cell Adenocarcinoma [NCIt concept]
- Endometrial Mucinous Adenocarcinoma [NCIt concept]
- Endometrial Mucinous Adenocarcinoma, Gastric-Type [NCIt concept]
- Endometrial Mucinous Adenocarcinoma, Intestinal-Type [NCIt concept]
- Endometrial Neuroendocrine Carcinoma [NCIt concept]
- Endometrial Serous Adenocarcinoma [NCIt concept]
- Endometrial Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Endometrial Squamous Cell Carcinoma [NCIt concept]
- Endometrial Transitional Cell Carcinoma [NCIt concept]
- Endometrial Undifferentiated Carcinoma [NCIt concept]
- FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma [NCIt concept]
- FIGO Grade 1 Endometrial Mucinous Adenocarcinoma [NCIt concept]
- FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma [NCIt concept]
- FIGO Grade 2 Endometrial Mucinous Adenocarcinoma [NCIt concept]
- FIGO Grade 3 Endometrial Mucinous Adenocarcinoma [NCIt concept]
- FOXL2 c.402C>G (p.Cys134Trp)-Mutant Ovarian Sertoli-Leydig Cell Tumor [NCIt concept]
- High Grade Endometrial Carcinoma [NCIt concept]
- Hypermutated/MMRd Endometrial Carcinoma [NCIt concept]
- Hypermutated/MMRd Endometrial Endometrioid Adenocarcinoma [NCIt concept]
- Locally Advanced Endometrial Adenocarcinoma [NCIt concept]
- Locally Advanced Endometrial Carcinoma [NCIt concept]
- Locally Advanced Endometrial Endometrioid Adenocarcinoma [NCIt concept]
- Locally Advanced Unresectable Endometrial Carcinoma [NCIt concept]
- Locally Recurrent Endometrial Carcinoma [NCIt concept]
- Metastatic Endometrial Adenocarcinoma [NCIt concept]
- Metastatic Endometrial Adenosquamous Carcinoma [NCIt concept]
- Metastatic Endometrial Carcinoma [NCIt concept]
- Metastatic Endometrial Clear Cell Adenocarcinoma [NCIt concept]
- Metastatic Endometrial Endometrioid Adenocarcinoma [NCIt concept]
- Metastatic Endometrial Mixed Cell Adenocarcinoma [NCIt concept]
- Metastatic Endometrial Serous Adenocarcinoma [NCIt concept]
- Metastatic Endometrial Undifferentiated Carcinoma [NCIt concept]
- Metastatic Microsatellite Stable Endometrial Carcinoma [NCIt concept]
- Microsatellite Stable Endometrial Carcinoma [NCIt concept]
- Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor [NCIt concept]
- Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements [NCIt concept]
- No Specific Molecular Profile Endometrial Endometrioid Adenocarcinoma [NCIt concept]
- Ovarian Retiform Sertoli-Leydig Cell Tumor [NCIt concept]
- Ovarian Retiform Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements [NCIt concept]
- Ovarian Sertoli-Leydig Cell Tumor [NCIt concept]
- Ovarian Sertoli-Leydig Cell Tumor Molecular Subtypes [NCIt concept]
- Ovarian Sertoli-Leydig Cell Tumor with Heterologous Elements [NCIt concept]
- Ovarian Sertoli-Leydig Cell Tumor with Retiform Elements [NCIt concept]
- Oxyphilic Endometrial Endometrioid Adenocarcinoma [NCIt concept]
- POLEm Endometrial Carcinoma [NCIt concept]
- POLEm Endometrial Endometrioid Adenocarcinoma [NCIt concept]
- Platinum-Resistant Endometrial Carcinoma [NCIt concept]
- Platinum-Sensitive Endometrial Carcinoma [NCIt concept]
- Platinum-Sensitive Endometrial Serous Adenocarcinoma [NCIt concept]
- Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor [NCIt concept]
- Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements [NCIt concept]
- Recurrent Endometrial Adenocarcinoma [NCIt concept]
- Recurrent Endometrial Adenosquamous Carcinoma [NCIt concept]
- Recurrent Endometrial Carcinoma [NCIt concept]
- Recurrent Endometrial Clear Cell Adenocarcinoma [NCIt concept]
- Recurrent Endometrial Dedifferentiated Carcinoma [NCIt concept]
- Recurrent Endometrial Endometrioid Adenocarcinoma [NCIt concept]
- Recurrent Endometrial High Grade Endometrioid Adenocarcinoma [NCIt concept]
- Recurrent Endometrial Low Grade Endometrioid Adenocarcinoma [NCIt concept]
- Recurrent Endometrial Mixed Cell Adenocarcinoma [NCIt concept]
- Recurrent Endometrial Mucinous Adenocarcinoma [NCIt concept]
- Recurrent Endometrial Serous Adenocarcinoma [NCIt concept]
- Recurrent Endometrial Squamous Cell Carcinoma [NCIt concept]
- Recurrent Endometrial Transitional Cell Carcinoma [NCIt concept]
- Recurrent Endometrial Undifferentiated Carcinoma [NCIt concept]
- Recurrent Platinum-Resistant Endometrial Carcinoma [NCIt concept]
- Recurrent Platinum-Sensitive Endometrial Carcinoma [NCIt concept]
- Refractory Endometrial Adenocarcinoma [NCIt concept]
- Refractory Endometrial Carcinoma [NCIt concept]
- Refractory Endometrial Clear Cell Adenocarcinoma [NCIt concept]
- Refractory Endometrial Dedifferentiated Carcinoma [NCIt concept]
- Refractory Endometrial Endometrioid Adenocarcinoma [NCIt concept]
- Refractory Endometrial Mixed Cell Adenocarcinoma [NCIt concept]
- Refractory Endometrial Mucinous Adenocarcinoma [NCIt concept]
- Refractory Endometrial Serous Adenocarcinoma [NCIt concept]
- Refractory Endometrial Squamous Cell Carcinoma [NCIt concept]
- Refractory Endometrial Transitional Cell Carcinoma [NCIt concept]
- Refractory Endometrial Undifferentiated Carcinoma [NCIt concept]
- Refractory Microsatellite Stable Endometrial Carcinoma [NCIt concept]
- Resectable Endometrial Carcinoma [NCIt concept]
- Serous Endometrial Intraepithelial Carcinoma [NCIt concept]
- Stage I Endometrial Cancer FIGO 2023 [NCIt concept]
- Stage IA1 Endometrial Cancer FIGO 2023 [NCIt concept]
- Stage IA2 Endometrial Cancer FIGO 2023 [NCIt concept]
- Stage IA3 Endometrial Cancer FIGO 2023 [NCIt concept]
- Stage IAmPOLEm Endometrial Cancer FIGO 2023 [NCIt concept]
- Stage IB Endometrial Cancer FIGO 2023 [NCIt concept]
- Stage IC Endometrial Cancer FIGO 2023 [NCIt concept]
- Stage II Endometrial Cancer FIGO 2023 [NCIt concept]
- Stage IIA Endometrial Cancer FIGO 2023 [NCIt concept]
- Stage IIB Endometrial Cancer FIGO 2023 [NCIt concept]
- Stage IIC Endometrial Cancer FIGO 2023 [NCIt concept]
- Stage IICmp53abn Endometrial Cancer FIGO 2023 [NCIt concept]
- Stage III Endometrial Cancer FIGO 2023 [NCIt concept]
- Stage IIIA Endometrial Cancer FIGO 2023 [NCIt concept]
- Stage IIIA1 Endometrial Cancer FIGO 2023 [NCIt concept]
- Stage IIIA2 Endometrial Cancer FIGO 2023 [NCIt concept]
- Stage IIIB Endometrial Cancer FIGO 2023 [NCIt concept]
- Stage IIIB1 Endometrial Cancer FIGO 2023 [NCIt concept]
- Stage IIIB2 Endometrial Cancer FIGO 2023 [NCIt concept]
- Stage IIIC Endometrial Cancer FIGO 2023 [NCIt concept]
- Stage IIIC1 Endometrial Cancer FIGO 2023 [NCIt concept]
- Stage IIIC1i Endometrial Cancer FIGO 2023 [NCIt concept]
- Stage IIIC1ii Endometrial Cancer FIGO 2023 [NCIt concept]
- Stage IIIC2 Endometrial Cancer FIGO 2023 [NCIt concept]
- Stage IIIC2i Endometrial Cancer FIGO 2023 [NCIt concept]
- Stage IIIC2ii Endometrial Cancer FIGO 2023 [NCIt concept]
- Stage IV Endometrial Cancer FIGO 2023 [NCIt concept]
- Stage IVA Endometrial Cancer FIGO 2023 [NCIt concept]
- Stage IVB Endometrial Cancer FIGO 2023 [NCIt concept]
- Stage IVC Endometrial Cancer FIGO 2023 [NCIt concept]
- Type I Endometrial Adenocarcinoma [NCIt concept]
- Type II Endometrial Adenocarcinoma [NCIt concept]
- Unresectable Endometrial Carcinoma [NCIt concept]
- Villoglandular Endometrial Endometrioid Adenocarcinoma [NCIt concept]
- Well Differentiated Ovarian Sertoli-Leydig Cell Tumor [NCIt concept]
- p53abn Endometrial Carcinoma [NCIt concept]
- p53abn Endometrial Endometrioid Adenocarcinoma [NCIt concept]
Semantic type(s)
- Pathologic Function [UMLS semantic type]
UMLS correspondences (same concept)
- Bleeding between periods (finding) [SNOMED CT concept]
- Bleeding intermenstrual [MedDRA LLT]
- Dysfunctional uterine bleeding [MedDRA Preferred Term]
- Dysfunctional uterine bleeding [MedDRA LLT]
- Dysfunctional uterine bleeding (finding) [Inactive SNOMED CT concept]
- Dysfunctional uterine haemorrhage [MedDRA LLT]
- Dysfunctional uterine hemorrhage [MedDRA LLT]
- Intermenstrual bleeding [MedDRA LLT]
- Intermenstrual bleeding [MedDRA Preferred Term]
- Irregular intermenstrual bleeding (finding) [SNOMED CT concept]
- METRORRHAGIA [WHO-ART Included Term]
- Metrorrhagia [MedDRA Preferred Term]
- Metrorrhagia [ICD-9 code]
- Metrorrhagia [HPO term]
- Metrorrhagia [PASCAL descriptor]
- Metrorrhagia [MedDRA LLT]
- Spotting between menses [MedDRA LLT]
- dysfunctional uterine bleeding [SNOMED Notion]
- intermenstrual bleeding [ICPC-2 Rubric]
- metrorrhagia [Disease (Nov.)]
- metrorrhagia [MeSH concept]
- metrorrhagia [MeSH Descriptor]
- metrorrhagia [SNOMED Notion]
Validated automatic mappings to BTNT
- Excessive and frequent menstruation with irregular cycle [ICD-10 Sub-category]
concept_is_in_subset
- CDRH Health Effects - Clinical Signs and Symptoms or Conditions Terminology [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients